IMMUNO-ONCOLOGY INSIGHTS

Volume 3 Issue 11

Issue 11 (December)

FEATURING

Issue Spotlight: Immuno-oncology: tools of tomorrow 2023

Volume 3 Issue 10

Issue 10 (November)

FEATURING

Issue Spotlight: Combination therapy development: emerging I-O therapeutic modalities and predictive technologies

Volume 3 Issue 9

Issue 9 (October)

FEATURING

Issue Spotlight: Leveraging the cutting-edge TME toolkit

Volume 3 Issue 8

Issue 8 (September)

FEATURING

Issue Spotlight: Nonclinical tools update: are they improving in their capabilities of predicting clinical responses?

Volume 3 Issue 7

Issue 7 (July)

FEATURING

Issue Spotlight: How to move towards precision I-O? Innovation in biomarker R&D

Volume 3 Issue 6

Issue 6 (June)

FEATURING

Issue Spotlight: Safety: what progress in understanding and addressing immune-related adverse events?

Volume 3 Issue 5

Issue 5 (May)

FEATURING

Issue Spotlight: Combination therapy development: strategic directions towards improving current I-O response rates

Volume 3 Issue 3

Issue 3 (April)

FEATURING

Issue Spotlight: Optimizing clinical development strategy for the rapidly evolving I-O field

Volume 3 Issue 4

Issue 4 (April)

FEATURING

Issue Spotlight: Novel target and pathways: driving new approaches to tackling the TME and resistance to I-O therapeutics

Volume 3 Issue 2

Issue 2 (February)

FEATURING

Issue Spotlight: Dissecting investor and market access trends and drivers for I-O R&D insights

Volume 3 Issue 1

Issue 1 (January)

FEATURING

Issue Spotlight: Anticipating immuno-oncology modality/platform development trends for 2022